# Lucid News > Research FDA Holds Historic Public Hearing on Psychedelic Therapies by Jack Gorsline September 22, 2026 Health Psychedelic Policy Briefing 8.21.26 Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New Drug Application (NDA) for MDMA-assisted therapy for PTSD to the FDA, triggering a fresh review cycle under the agency’s newly finalized psychedelic Location: Global ## Categories - Healthcare & Medical ## Documents - [Business profile](https://directory.websdocs.com/business/lucid-news) - [Directory JSON](https://directory.websdocs.com/business/lucid-news.json) - [Schema.org JSON-LD](https://directory.websdocs.com/business/lucid-news/schema.jsonld) - [Directory sitemap](https://directory.websdocs.com/sitemap.xml) - [Directory discovery manifest](https://directory.websdocs.com/.well-known/asg-directory.json) - [Directory OpenAPI](https://directory.websdocs.com/api/openapi.json) - [Official website](https://lucid.news/)